Peptides: Tesamorelin, AOD9604, Tirzepatide (GLP-1 agonist) Tesamorelin is FDA-approved to reduce visceral adipose tissue (VAT) in HIV-associated lipodystrophy, but its fat-burning effects also appear in non-HIV populations AOD9604 is a modified fragment of human GH (176191) shown in animal and early human trials to enhance lipolysis without altering blood sugar or cortisol Tirzepatide , while technically a GLP-1/GIP agonist , is now frequently stacked with peptides in clinical practice to accelerate fat loss and appetite control
Prescription GLP-1 receptor agonists work by directly binding to GLP-1 receptors and activating them continuously
330 A normal D-dimer level indicates a diagnosis other than thrombosis
Bilezikian JP, Watts NB, Usiskin K, Polidori D, Fung A, Sullivan D, Rosenthal N
Made in Japan Manufactured by an ISO Certified, HALAL Certified, GMP Certified Institution ** Everyone reacts differently to products